Table 3. Association of PhIP-DNA Adduct Levels with Prostate Cancer, Stratified by Matching Factors and Case Characteristics.
Sample PhIP Level |
Whole Sample | African Americans | Whites | ||||||
---|---|---|---|---|---|---|---|---|---|
ORa | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
Low Tumor Grade | (n=367 case-control pairs) | (n = 137 case-control pairs) | (n = 230 case-control pairs) | ||||||
2nd Quartile | 1.40 | 0.84-2.31 | 0.19 | 1.94 | 0.83-4.55 | 0.13 | 1.17 | 0.62-2.19 | 0.63 |
3rd Quartile | 1.37 | 0.81-2.33 | 0.25 | 1.42 | 0.53-3.85 | 0.49 | 1.30 | 0.69-2.46 | 0.41 |
4th Quartile | 1.29 | 0.65-2.54 | 0.47 | 1.09 | 0.30-4.01 | 0.90 | 1.36 | 0.61-3.04 | 0.46 |
Trend Test | 0.51 | 0.98 | 0.43 | ||||||
High Tumor Grade | (n= 138 case-control pairs) | (n = 56 case-control pairs) | (n = 82 case-control pairs) | ||||||
2nd Quartile | 0.92 | 0.45-1.86 | 0.81 | 1.14 | 0.38-3.44 | 0.82 | 0.87 | 0.33-2.28 | 0.77 |
3rd Quartile | 1.57 | 0.68-3.65 | 0.29 | 0.94 | 0.22-4.08 | 0.93 | 2.04 | 0.69-6.07 | 0.20 |
4th Quartile | 1.03 | 0.31-3.39 | 0.97 | 0.45 | 0.07-2.96 | 0.41 | 1.84 | 0.34-10.00 | 0.48 |
Trend Test | 0.76 | 0.43 | 0.33 | ||||||
1-4 years of Follow-up | (n= 266 case-control pairs) | (n = 103 case-control pairs) | (n = 163 case-control pairs) | ||||||
2nd Quartile | 1.63 | 0.91-2.92 | 0.10 | 1.83 | 0.76-4.44 | 0.18 | 1.48 | 0.68-3.24 | 0.32 |
3rd Quartile | 1.46 | 0.75-2.84 | 0.27 | 0.99 | 0.31-3.16 | 0.99 | 1.68 | 0.74-3.84 | 0.22 |
4th Quartile | 1.15 | 0.49-2.69 | 0.74 | 0.95 | 0.23-4.02 | 0.95 | 1.23 | 0.42-3.55 | 0.71 |
Trend Test | 0.82 | 0.75 | 0.67 | ||||||
4-15 years of follow-up | (n= 267 case-control pairs) | (n = 110 case-control pairs) | (n = 157 case-control pairs) | ||||||
2nd Quartile | 0.90 | 0.51-1.58 | 0.72 | 0.82 | 0.32-2.11 | 0.67 | 0.99 | 0.48-2.05 | 0.99 |
3rd Quartile | 1.34 | 0.75-2.37 | 0.32 | 0.90 | 0.32-2.55 | 0.84 | 1.60 | 0.78-3.27 | 0.20 |
4th Quartile | 1.46 | 0.70-3.03 | 0.31 | 0.62 | 0.17-2.18 | 0.45 | 2.74 | 1.01-7.42 | 0.05 |
Trend Test | 0.21 | 0.53 | 0.03 | ||||||
Early Cohort entry | (n = 263 case-control pairs) | (n = 88 case-control pairs) | (n = 175 case-control pairs) | ||||||
2nd Quartile | 1.28 | 0.69-2.40 | 0.44 | 2.46 | 0.69-8.76 | 0.17 | 1.02 | 0.49-2.12 | 0.96 |
3rd Quartile | 1.28 | 0.68-2.40 | 0.44 | 1.92 | 0.56-6.53 | 0.30 | 1.09 | 0.52-2.29 | 0.83 |
4th Quartile | 1.73 | 0.78-3.86 | 0.18 | 2.76 | 0.60-12.75 | 0.19 | 1.42 | 0.54-3.72 | 0.48 |
Trend Test | 0.21 | 0.27 | 0.47 | ||||||
Late Cohort entry | (n=270 case-control pairs) | (n = 125 case-control pairs) | (n = 145 case-control pairs) | ||||||
2nd Quartile | 1.10 | 0.67-1.84 | 0.69 | 1.00 | 0.48-2.10 | 1.00 | 1.14 | 0.55-2.36 | 0.72 |
3rd Quartile | 1.40 | 0.76-2.57 | 0.28 | 0.60 | 0.20-1.77 | 0.35 | 2.18 | 0.99-4.78 | 0.05 |
4th Quartile | 0.98 | 0.46-2.13 | 0.97 | 0.29 | 0.08-1.08 | 0.06 | 2.14 | 0.73-6.24 | 0.16 |
Trend Test | 0.89 | 0.06 | 0.09 | ||||||
Age <65 | (n=274 case-control pairs) | (n = 110 case-control pairs) | (n = 164 case-control pairs) | ||||||
2nd Quartile | 1.30 | 0.72-2.35 | 0.39 | 0.92 | 0.38-2.24 | 0.85 | 1.79 | 0.79-4.09 | 0.16 |
3rd Quartile | 1.35 | 0.72-2.53 | 0.35 | 0.95 | 0.35-2.60 | 0.92 | 1.71 | 0.74-3.95 | 0.21 |
4th Quartile | 1.08 | 0.47-2.47 | 0.85 | 0.38 | 0.10-1.42 | 0.15 | 2.80 | 0.87-8.97 | 0.08 |
Trend Test | 0.83 | 0.18 | 0.09 | ||||||
Age 65+ | (n=259 case-control pairs) | (n = 103 case-control pairs) | (n = 156 case-control pairs) | ||||||
2nd Quartile | 1.10 | 0.64-1.89 | 0.72 | 1.71 | 0.65-4.50 | 0.27 | 0.82 | 0.41-1.62 | 0.56 |
3rd Quartile | 1.45 | 0.79-2.67 | 0.23 | 1.02 | 0.29-3.60 | 0.97 | 1.55 | 0.76-3.16 | 0.22 |
4th Quartile | 1.54 | 0.72-3.29 | 0.26 | 1.52 | 0.33-7.03 | 0.59 | 1.46 | 0.57-3.45 | 0.47 |
Trend Test | 0.23 | 0.78 | 0.28 |
all risk estimates use lowest quartile as referent group